Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis - Related Studies

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

This study has been completed.

Study NCT00111553. Last updated on February 13, 2007. Information provided by Infectious Disease Research Institute

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leishmaniasis, Cutaneous

2	Additional conditions recognized in this trial
		Leishmaniasis

3	More general conditions related to this trial
		Mastigophora Infections
		Parasitic Diseases
		Protozoan Infections
		Sarcomastigophora Infections
		Skin Diseases
		Skin Diseases, Infectious
		Skin Diseases, Parasitic

4	Interventions listed in this trial
		Leish-111f + MPL-SE vaccine

5	Sponsors listed in this trial
		Infectious Disease Research Institute
		Bill and Melinda Gates Foundation